ANNX Annexon Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ANNX

Price (delayed)

$5.46

Market cap

$894.58M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.2

Enterprise value

$743.77M

?
Relative Growth: Rel. Growth: 8
Relative Strength: Rel. Strength: 80
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 4

Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain and eye. The company’s pipeline is based on ...

Highlights
Annexon's debt has decreased by 10% YoY and by 2.9% from the previous quarter
Annexon's EPS has increased by 10% QoQ
Annexon's quick ratio has decreased by 20% YoY but it has increased by 12% from the previous quarter
The company's net income fell by 17% YoY but it rose by 4.9% QoQ
The equity has declined by 16% year-on-year and by 3.4% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.annexonbio.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of ANNX

ANNX stock price

How has the Annexon stock price performed over time
Intraday
-1.62%
1 week
6.02%
1 month
3.8%
1 year
94.31%
YTD
8.76%
QTD
-4.38%

Financial performance

How have Annexon's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$205.06M
Net income
-$196.48M
Gross margin
N/A
Net margin
N/A
The company's net income fell by 17% YoY but it rose by 4.9% QoQ
The company's operating income fell by 12% YoY but it rose by 5% QoQ

Price vs fundamentals

How does ANNX's price correlate with its fundamentals

Growth

What is Annexon's growth rate over time

Valuation

What is Annexon stock price valuation
P/E
N/A
P/B
4.28
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Annexon's EPS has increased by 10% QoQ
The P/B is 168% higher than the 5-year quarterly average of 1.6 and 65% higher than the last 4 quarters average of 2.6
The equity has declined by 16% year-on-year and by 3.4% since the previous quarter

Efficiency

How efficient is Annexon business performance
The ROE has dropped by 87% year-on-year
ANNX's ROA has shrunk by 65% YoY
The return on invested capital has declined by 27% since the previous quarter

Dividends

What is ANNX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ANNX.

Financial health

How did Annexon financials performed over time
Annexon's current ratio has decreased by 21% YoY but it has increased by 12% from the previous quarter
Annexon's quick ratio has decreased by 20% YoY but it has increased by 12% from the previous quarter
Annexon's debt is 88% less than its equity
The equity has declined by 16% year-on-year and by 3.4% since the previous quarter
Annexon's debt has decreased by 10% YoY and by 2.9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.